☰

Daniel Cahill - Publications

Affiliations: 
Neurosurgery M. D. Anderson Cancer Center, Houston, TX, United States 
Website:
http://faculty.mdanderson.org/Daniel_Cahill/Default.asp?SNID=998364111
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tateishi K, Miyake Y, Nakamura T, Iwashita H, Hayashi T, Oshima A, Honma H, Hayashi H, Sugino K, Kato M, Satomi K, Fujii S, Komori T, Yamamoto T, Cahill DP, et al. Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma. Acta Neuropathologica Communications. 11: 186. PMID 38012788 DOI: 10.1186/s40478-023-01683-x  0.312
2022 Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL, Bindra R, Cahill DP, Chang SM, Costello JF, et al. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology. PMID 36239925 DOI: 10.1093/neuonc/noac207  0.464
2021 Mathewson ND, Ashenberg O, Tirosh I, Gritsch S, Perez EM, Marx S, Jerby-Arnon L, Chanoch-Myers R, Hara T, Richman AR, Ito Y, Pyrdol J, Friedrich M, Schumann K, Poitras MJ, ... ... Cahill DP, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. PMID 33592174 DOI: 10.1016/j.cell.2021.01.022  0.449
2020 Richardson LG, Nieman LT, Stemmer-Rachamimov AO, Zheng XS, Stafford K, Nagashima H, Miller JJ, Kiyokawa J, Ting DT, Wakimoto H, Cahill DP, Choi BD, Curry WT. IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice. Oncoimmunology. 9: 1806662. PMID 32923170 DOI: 10.1080/2162402X.2020.1806662  0.531
2020 Park JW, Sahm F, Steffl B, Arrillaga-Romany I, Cahill D, Monje M, Herold-Mende C, Wick W, Turcan Ş. TERT and DNMT1 expression predict sensitivity to decitabine in gliomas. Neuro-Oncology. PMID 32882013 DOI: 10.1093/Neuonc/Noaa207  0.362
2019 Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, ... ... Cahill DP, et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. PMID 31327527 DOI: 10.1016/J.Cell.2019.06.024  0.628
2019 Tanaka S, Batchelor TT, Iafrate AJ, Dias-Santagata D, Borger DR, Ellisen LW, Yang D, Louis DN, Cahill DP, Chi AS. PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma. Acta Neuropathologica Communications. 7: 66. PMID 31036078 DOI: 10.1186/S40478-019-0720-8  0.495
2019 Juratli T, Jones P, Wang N, Subramanian M, Aylwin S, Odia Y, Rostami E, Gudjonsson O, Shaw B, Cahill D, Uhm J, Galanis E, Barker F, Santagata S, Brastianos P. Rare-04. Targeted Treatment Of Papillary Craniopharyngiomas Harboring Brafv600E Mutations Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.927  0.316
2019 Wang N, Cohen J, Goss N, Bertalan M, Keeley M, Parsons M, Nahed B, Cahill D, Oh K, Brastianos P. Innv-27. The Impact Of A Dedicated Multidisciplinary Tumor Board On Care For Patients With Brain Metastases Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.568  0.335
2018 Bale TA, Jordan JT, Rapalino O, Ramamurthy N, Jessop N, DeWitt JC, Nardi V, Martinez-Lage Alvarez M, Frosch M, Batchelor TT, Louis DN, Iafrate AJ, Cahill DP, Lennerz JK. Financially Effective Test-Algorithm to Identify an Aggressive, EGFR-amplified Variant of IDH-Wildtype, Lower-Grade Diffuse Glioma. Neuro-Oncology. PMID 30496526 DOI: 10.1093/Neuonc/Noy201  0.393
2018 Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, ... ... Cahill DP, et al. DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome. Acta Neuropathologica. PMID 30123936 DOI: 10.1007/S00401-018-1899-7  0.548
2018 Ly KI, Oakley DH, Pine AB, Frosch MP, Chiou SH, Betensky RA, Pomerantz SR, Hochberg FH, Batchelor TT, Cahill DP, Dietrich J. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study. The Oncologist. PMID 30097523 DOI: 10.1634/Theoncologist.2018-0086  0.643
2018 Bunse L, Pusch S, Bunse T, Sahm F, Sanghvi K, Friedrich M, Alansary D, Sonner JK, Green E, Deumelandt K, Kilian M, Neftel C, Uhlig S, Kessler T, von Landenberg A, ... ... Cahill DP, et al. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nature Medicine. PMID 29988124 DOI: 10.1038/S41591-018-0095-6  0.437
2018 Cahill D, Turcan S. Origin of Gliomas. Seminars in Neurology. 38: 5-10. PMID 29548046 DOI: 10.1055/S-0037-1620238  0.375
2018 Fujio S, Juratli T, Arita K, Hirano H, Nagano Y, Takajo T, Curry W, Jones P, Martinez-Lage M, Cahill D, Barker F, Brastianos P. Nimg-64. A Clinical Rule For Preoperative Prediction Of Braf Mutation Status In Craniopharyngiomas Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.788  0.311
2018 Alvarez-Breckenridge C, Izar B, Stocking J, Lastrapes M, Nayyar N, Gill C, Bertalan M, Kaplan A, McCabe D, Johnson D, Horbinski C, Zakaria R, Nassiri F, Zadeh G, Fisher D, ... ... Cahill D, et al. GENE-18. DIVERGENT CLONAL EVOLUTION OF MELANOMA BRAIN METASTASES DURING TREATMENT WITH IMMUNOTHERAPY Neuro-Oncology. 20: vi106-vi107. DOI: 10.1093/Neuonc/Noy148.444  0.306
2018 Tateishi K, Nakamura T, Fink A, Lelic N, Matsushita Y, Koerner M, Murata H, Ichimura K, Batchelor T, Yamamoto T, Chi A, Iafrate J, Wakimoto H, Cahill D. Csig-34. Pi3 Kinase Pathway Activation Promotes Malignant Progression In Oligodendroglial Tumors Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.200  0.315
2017 Alvarez-Breckenridge C, Miller JJ, Nayyar N, Gill CM, Kaneb A, D'Andrea M, Le LP, Lee J, Cheng J, Zheng Z, Butler WE, Multani P, Chow Maneval E, Ha Paek S, Toyota BD, ... ... Cahill DP, et al. Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. Npj Precision Oncology. 1: 5. PMID 29872694 DOI: 10.1038/s41698-017-0009-y  0.507
2017 Miller JJ, Shih HA, Andronesi OC, Cahill DP. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications. Cancer. PMID 28980701 DOI: 10.1002/cncr.31039  0.313
2017 Figueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, ... Cahill D, et al. Detection of wtEGFR Amplification and EGFRvIII Mutation in CSF-Derived Extracellular Vesicles of Glioblastoma Patients. Neuro-Oncology. PMID 28453784 DOI: 10.1093/Neuonc/Nox085  0.321
2017 Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin MG, Hovestadt V, Escalante LE, Shaw ML, Rodman C, Gillespie SM, Dionne D, Luo CC, Ravichandran H, Mylvaganam R, ... ... Cahill DP, et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science (New York, N.Y.). 355. PMID 28360267 DOI: 10.1126/Science.Aai8478  0.492
2017 Loebel F, Winter SF, Onken J, Cahill D, Koch A, Dietrich J. Path-18. Molecular And Genetic Analysis Identifies Idh Mutation As A Key Factor Of Long-Term Survival In Glioblastoma Patients Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.709  0.325
2017 Brastianos PK, Alvarez-Breckenridge C, Miller JJ, Nayyar N, Gill C, Dias-Santagata D, Santagata S, Multani P, Yip S, Cahill D, Iafrate AJ, Batchelor T. OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor Neuro-Oncology. 19: iii11-iii11. DOI: 10.1093/Neuonc/Nox036.038  0.497
2016 Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, ... ... Cahill DP, et al. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro-Oncology. PMID 28170043 DOI: 10.1093/Neuonc/Now235  0.518
2016 Chi AS, Cahill DP, Larvie M, Louis DN. Case 38-2016. The New England Journal of Medicine. 375: 2381-2389. PMID 27974037 DOI: 10.1056/Nejmcpc1610101  0.367
2016 Tirosh I, Venteicher AS, Hebert C, Escalante LE, Patel AP, Yizhak K, Fisher JM, Rodman C, Mount C, Filbin MG, Neftel C, Desai N, Nyman J, Izar B, Luo CC, ... ... Cahill DP, et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature. PMID 27806376 DOI: 10.1038/Nature20123  0.45
2016 Marusyk A, Tabassum D, Janiszewska M, Place A, Trinh A, Rozhok AI, Pyne S, Guerrierro J, Shu S, Ekram M, Ishkin A, Cahill DP, Nikolsky Y, Chan TA, Rimawi MF, et al. Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes. Cancer Research. PMID 27671678 DOI: 10.1158/0008-5472.Can-16-1457  0.453
2016 Venteicher AS, Tirosh I, Hebert C, Escalante L, Martuza RL, Nahed BV, Curry WT, Cahill DP, Bernstein B, Louis DN, Regev A, Suva M. 142 Genetic and Nongenetic Determinants of Cellular Architecture in IDH1-Mutant Oligodendrogliomas and Astrocytomas Using Single-Cell Transcriptome Analysis. Neurosurgery. 63: 158. PMID 27399421 DOI: 10.1227/01.Neu.0000489712.44702.0D  0.528
2016 Ho AL, Koch MJ, Tanaka S, Eichler AF, Batchelor TT, Tanboon J, Louis DN, Cahill DP, Chi AS, Curry WT. Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 27279154 DOI: 10.1016/J.Jocn.2016.02.019  0.432
2016 Nigim F, Esaki SI, Hood M, Lelic N, James MF, Ramesh V, Stemmer-Rachamimov A, Cahill DP, Brastianos PK, Rabkin SD, Martuza RL, Wakimoto H. A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. Neuro-Oncology. PMID 26951380 DOI: 10.1093/Neuonc/Now031  0.491
2016 Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS, Dunn IF, Nahed BV, Romero JM, Louis DN, Getz G, ... Cahill DP, et al. Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. Journal of the National Cancer Institute. 108. PMID 26498373 DOI: 10.1093/Jnci/Djv310  0.484
2016 Juratli T, Kirsch M, Thiede C, Krex D, Krause M, Brastianos P, Cahill D, Schackert G. Mngo-12. Clonal Selection Toward Tert Promoter Mutations In Progressive Recurrent Meningiomas Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.433  0.337
2016 Filbin M, Tirosh I, Neftel C, Hovestadt V, Venteicher A, Hebert C, Shaw M, Escalante L, Pelton K, Goumnerova L, Czech T, Slavc I, Monje M, Bandopadhayay P, Nahed B, ... ... Cahill D, et al. GENT-16. REDEFINING THE CELLULAR ARCHITECTURE OF ADULT AND PEDIATRIC GLIOBLASTOMAS THROUGH LARGE-SCALE SINGLE-CELL ANALYSES Neuro-Oncology. 18: vi77-vi77. DOI: 10.1093/Neuonc/Now212.322  0.443
2015 Cahill DP, Louis DN, Cairncross JG. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1. Cns Oncology. PMID 26545048 DOI: 10.2217/Cns.15.32  0.504
2015 Cahill DP, Sloan AE, Nahed BV, Aldape KD, Louis DN, Ryken TC, Kalkanis SN, Olson JJ. The role of neuropathology in the management of patients with diffuse low grade glioma : A systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology. PMID 26530263 DOI: 10.1007/S11060-015-1909-8  0.4
2015 Shankar GM, Lelic N, Gill CM, Thorner AR, Van Hummelen P, Wisoff JH, Loeffler JS, Brastianos PK, Shin JH, Borges LF, Butler WE, Zagzag D, Brody RI, Duhaime AC, Taylor MD, ... ... Cahill DP, et al. BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology. Acta Neuropathologica. PMID 26487540 DOI: 10.1007/S00401-015-1492-2  0.481
2015 Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, et al. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discovery. PMID 26410082 DOI: 10.1158/2159-8290.Cd-15-0369  0.628
2015 Shankar GM, Francis JM, Rinne ML, Ramkissoon SH, Huang FW, Venteicher AS, Akama-Garren EH, Kang YJ, Lelic N, Kim JC, Brown LE, Charbonneau SK, Golby AJ, Sekhar Pedamallu C, Hoang MP, ... ... Cahill DP, et al. Rapid Intraoperative Molecular Characterization of Glioma. Jama Oncology. PMID 26181761 DOI: 10.1001/Jamaoncol.2015.0917  0.597
2015 Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS. Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. Journal of Neuro-Oncology. 121: 557-63. PMID 25411098 DOI: 10.1007/S11060-014-1667-Z  0.523
2015 Olar A, Wani K, Diefes K, Heathcock L, Thuijl Hv, Gilbert M, Armstrong T, Sulman E, Cahill D, Reijneveld J, Ylstra B, Wesseling P, Aldape K. Abstract 5270: IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas Cancer Research. 75: 5270-5270. DOI: 10.1158/1538-7445.Am2015-5270  0.401
2015 Brastianos PK, Carter SL, Santagata S, Taylor-Weiner A, Jones RT, Allen EV, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Cahill D, Curry WT, Dunn IF, Paek SH, Hummelen PV, et al. Abstract 4727: Genomic characterization of brain metastases reveals divergent evolution and metastasis specific mutations Brain. 75: 4727-4727. DOI: 10.1158/1538-7445.Am2015-4727  0.657
2015 Tummala S, Cahill D. Surg-05Molecular Correlates Of Tumor Size And Mri Contrast Enhancement In A Cohort Of Lower-Grade Glioma Patients Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov235.05  0.376
2015 Venteicher A, Tirosh I, Hebert C, Escalante L, Nahed B, Cahill D, Curry W, Martuza R, Bernstein B, Louis D, Regev A, Suva M. STEM-22LARGE-SCALE SINGLE-CELL RNA-seq REVEALS A DEVELOPMENTAL CELLULAR HIERARCHY IN HUMAN OLIGODENDROGLIOMA Neuro-Oncology. 17: v212.4-v213. DOI: 10.1093/Neuonc/Nov234.22  0.56
2015 Kesler S, Noll K, Cahill D, Rao G, Wefel J. NIMG-42LOWER BRAIN NETWORK EFFICIENCY IN IDH1 WILD TYPE (IDH-WT) MALIGNANT ASTROCYTOMA COMPARED TO IDH1 MUTANT (IDH1-M) Neuro-Oncology. 17: v163.2-v163. DOI: 10.1093/Neuonc/Nov225.42  0.336
2015 Jafari-Khouzani K, Loebel F, Bogner W, Gerstner E, Chi A, Batchelor T, Rosen B, Unkelbach J, Shih H, Cahill D, Andronesi O. NIMG-02VOLUMETRIC RELATIONSHIP BETWEEN 2-HYDROXYGLUTARATE AND FLAIR HYPERINTENSITY IN PATIENTS WITH MUTANT IDH1 GLIOMA Neuro-Oncology. 17: v153.2-v153. DOI: 10.1093/Neuonc/Nov225.02  0.343
2015 Nigim F, Rabkin SD, Brastianos P, Ramesh V, Cahill D, Santagata S, Martuza RL, Wakimoto H. MNGO-16ESTABLISHMENT OF A PATIENT - DERIVED ORTHOTOPIC MALIGNANT MENINGIOMA MODEL FOR THE DEVELOPMENT OF TARGETED THERAPY Neuro-Oncology. 17: v133.2-v133. DOI: 10.1093/Neuonc/Nov220.15  0.41
2015 Aquilanti E, Gill C, Santagata S, Lawrence D, Flaherty K, Cahill D, Sullivan R, Brastianos P. BMET-04LEPTOMENINGEAL CARCINOMATOSIS IN MELANOMA Neuro-Oncology. 17: v45.4-v45. DOI: 10.1093/Neuonc/Nov208.04  0.305
2015 Tateishi K, Wakimoto H, Loebel F, Lelic N, Zhao D, Batchelor T, Iafrate J, Chi A, Cahill D. Atps-852-Hydroxyglutarate Depletion Is Not Sufficient To Inhibit Growth Of Several Progressive Idh1 Mutant Solid Cancer Types Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.85  0.359
2014 Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans JV, Curry WT, Nahed BV, Shin JH, Paek SH, Park SH, Stewart C, ... ... Cahill DP, et al. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathologica Communications. 2: 167. PMID 25589003 DOI: 10.1186/S40478-014-0167-X  0.649
2014 Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suvà ML, Regev A, Bernstein BE. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (New York, N.Y.). 344: 1396-401. PMID 24925914 DOI: 10.1126/Science.1254257  0.462
2014 Ginat DT, Swearingen B, Curry W, Cahill D, Madsen J, Schaefer PW. 3 Tesla intraoperative MRI for brain tumor surgery. Journal of Magnetic Resonance Imaging : Jmri. 39: 1357-65. PMID 24921066 DOI: 10.1002/Jmri.24380  0.335
2014 Suvà ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, Curry WT, Martuza RL, Rivera MN, Rossetti N, Kasif S, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell. 157: 580-94. PMID 24726434 DOI: 10.1016/J.Cell.2014.02.030  0.469
2014 Huse JT, Wallace M, Aldape KD, Berger MS, Bettegowda C, Brat DJ, Cahill DP, Cloughesy T, Haas-Kogan DA, Marra M, Miller CR, Nelson SJ, Salama SR, Soffietti R, Wen PY, et al. Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop. Neuro-Oncology. 16: 173-8. PMID 24305708 DOI: 10.1093/Neuonc/Not229  0.456
2014 Wefel J, Noll K, Rao G, Cahill D. NC-15 * RELATIONSHIPS BETWEEN NEUROCOGNITIVE FUNCTIONING AND IDH1 GENETIC MUTATION STATUS IN MALIGNANT ASTROCYTOMA Neuro-Oncology. 16: v137-v137. DOI: 10.1093/Neuonc/Nou263.15  0.361
2014 Brastianos P, Carter S, Santagata S, Taylor-Weiner A, Jones R, Van Allen E, Horowitz P, Ligon K, Cahill D, Dunn I, Van Hummelen P, Lin N, Curry W, Stemmer-Rachamimov A, Beroukhim R, et al. BM-07 * GENOMIC CHARACTERIZATION OF BRAIN METASTASES REVEALS BRANCHED EVOLUTION AND METASTASIS-SPECIFIC MUTATIONS Neuro-Oncology. 16: v33-v33. DOI: 10.1093/Neuonc/Nou240.7  0.684
2013 Taylor JW, Chi AS, Cahill DP. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management. Oncology (Williston Park, N.Y.). 27: 504-14. PMID 23909061  0.322
2013 Adachi K, Sasaki H, Nagahisa S, Yoshida K, Hattori N, Nishiyama Y, Kawase T, Hasegawa M, Abe M, Hirose Y, Alentorn A, Marie Y, Poggioli S, Alshehhi H, Boisselier B, ... ... Cahill D, ... ... Cahill DP, et al. OMICS AND PROGNSTIC MARKERS Neuro-Oncology. 15: iii136-iii155. DOI: 10.1093/Neuonc/Not183  0.593
2013 Ambady P, Holdhoff M, Ferrigno C, Grossman S, Anderson MD, Liu D, Conrad C, Penas-Prado M, Gilbert MR, Yung AWK, Groot Jd, Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, ... ... Cahill D, et al. Neuro/Medical Oncology Neuro-Oncology. 15: 120-120. DOI: 10.1093/Neuonc/Not182  0.404
2013 Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Cahill D, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174  0.449
2012 Kozono D, Nitta M, Sampetrean O, Kimberly N, Kushwaha D, Merzon D, Ligon K, Zhu S, Zhu K, Kim TH, Kwon C, Becher O, Saya H, Chen CC, Donovan LK, ... ... Cahill D, et al. LAB-STEM CELLS Neuro-Oncology. 14: vi142-vi152. DOI: 10.1093/Neuonc/Nos239  0.419
2011 Snuderl M, Fazlollahi L, Le LP, Nitta M, Zhelyazkova BH, Davidson CJ, Akhavanfard S, Cahill DP, Aldape KD, Betensky RA, Louis DN, Iafrate AJ. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell. 20: 810-7. PMID 22137795 DOI: 10.1016/J.Ccr.2011.11.005  0.515
2011 Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G, Velculescu VE, Oba-Shinjo SM, Marie SK, Vogelstein B, Bigner D, et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science (New York, N.Y.). 333: 1453-5. PMID 21817013 DOI: 10.1126/Science.1210557  0.49
2009 Yip S, Miao J, Cahill DP, Iafrate AJ, Aldape K, Nutt CL, Louis DN. MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4622-9. PMID 19584161 DOI: 10.1158/1078-0432.Ccr-08-3012  0.728
2008 Cahill DP, Codd PJ, Batchelor TT, Curry WT, Louis DN. MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. Clinical Neurosurgery. 55: 165-71. PMID 19248684  0.383
2008 di Tomaso E, Frosch MP, Auluck PK, Cahill D, Duda DG, Plotkin SR, Loeffler JS, Sorensen AG, Batchelor TT, Jain RK. Characterization of blood vessels in brain autopsies of GBM patients who received antiangiogenic treatment Journal of Clinical Oncology. 26: 2009-2009. DOI: 10.1200/Jco.2008.26.15_Suppl.2009  0.661
2007 Cahill DP, Levine KK, Betensky RA, Codd PJ, Romany CA, Reavie LB, Batchelor TT, Futreal PA, Stratton MR, Curry WT, Iafrate AJ, Louis DN. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2038-45. PMID 17404084 DOI: 10.1158/1078-0432.Ccr-06-2149  0.517
2007 Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, ... ... Cahill DP, et al. Patterns of somatic mutation in human cancer genomes. Nature. 446: 153-8. PMID 17344846 DOI: 10.1038/Nature05610  0.47
2007 Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 11: 83-95. PMID 17222792 DOI: 10.1016/J.Ccr.2006.11.021  0.476
2006 Hunter C, Smith R, Cahill DP, Stephens P, Stevens C, Teague J, Greenman C, Edkins S, Bignell G, Davies H, O'Meara S, Parker A, Avis T, Barthorpe S, Brackenbury L, et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Research. 66: 3987-91. PMID 16618716 DOI: 10.1158/0008-5472.Can-06-0127  0.623
2004 Wang Z, Cummins JM, Shen D, Cahill DP, Jallepalli PV, Wang TL, Parsons DW, Traverso G, Awad M, Silliman N, Ptak J, Szabo S, Willson JK, Markowitz SD, Goldberg ML, et al. Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Research. 64: 2998-3001. PMID 15126332 DOI: 10.1158/0008-5472.Can-04-0587  0.744
2001 Sparks AB, Peterson SN, Bell C, Loftus BJ, Hocking L, Cahill DP, Frassica FJ, Streeten EA, Levine MA, Fraser CM, Adams MD, Broder S, Venter JC, Kinzler KW, Vogelstein B, et al. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma. Calcified Tissue International. 68: 151-5. PMID 11351498 DOI: 10.1007/S002230001211  0.372
2001 Bardelli A, Cahill DP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B, Lengauer C. Carcinogen-specific induction of genetic instability. Proceedings of the National Academy of Sciences of the United States of America. 98: 5770-5. PMID 11296254 DOI: 10.1073/Pnas.081082898  0.412
1999 Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. Trends in Cell Biology. 9: M57-60. PMID 10611684 DOI: 10.1016/S0168-9525(99)01874-0  0.43
1999 Cahill DP, da Costa LT, Carson-Walter EB, Kinzler KW, Vogelstein B, Lengauer C. Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics. 58: 181-7. PMID 10366450 DOI: 10.1006/Geno.1999.5831  0.433
1998 Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature. 392: 300-3. PMID 9521327 DOI: 10.1038/32688  0.525
Show low-probability matches.